Previous 10 | Next 10 |
San Diego, California--(Newsfile Corp. - January 24, 2023) - The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Fulgent Genetics, Inc. (NASDAQ: FLGT) shares. Investors who purchased Fulgent Genetics, Inc. (NASDAQ: FLGT) shares prior to 2021 and c...
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics”, “Fulgent” or the “company”) today announced the addition of Reggie Groves to its board of directors, effective January 3, 2023. “Reggie possesses a diverse business skill set and a glob...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors who avoided losing money this year are positioned to consider stocks that are strong conviction buys. An investment idea earns that level of faith when management demonstrates a consistent history of leadership. For...
Summary What started as a seemingly innocuous leadership transition at one of the country's leading molecular diagnostic firms, NeoGenomics, Inc., has evolved into something much more chaotic. After the departure of former NeoGenomics, Inc. CEO and company veteran Douglas VanOort last y...
Summary As the COVID testing frenzy winds down, FLGT is faced with a pleasant problem: what to do with the money it has amassed during the pandemic. Its $880 million dry powder represents a major war chest that can be used to fund acquisitions to fund future growth free of leverage or s...
SAN DIEGO, CA / ACCESSWIRE / December 5, 2022 / The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Fulgent Genetics, Inc. (NASDAQ: FLGT) shares. Investors who purchased Fulgent Genetics, Inc. (NASDAQ:FLGT) shares in November 2019 or earlier and contin...
Fulgent Genetics (NASDAQ: FLGT) has been a fascinating company to watch over the past few years. Since the end of 2019, its shares are up 187% compared to the S&P 500 's 23%. While that's an impressive market beat, there was a point in early 2021 when Fulgent's stock was up ...
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based genetic testing and therapeutics company focused on transforming patient care in oncology, infectious and rare diseases, reproductive health, and pathology, today announced...
Summary Bull says deep valued 1x EV/S (core biz), getting its Covid biz for free. Bear says self-dealing, disregard of shareholder interests, and zero corporate governance left. I present both cases and my (painful) reflection. Bull Case As many SA authors covere...
The following slide deck was published by Fulgent Genetics, Inc. in conjunction with their 2022 Q3 earnings call. For further details see: Fulgent Genetics, Inc. 2022 Q3 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
Fulgent Genetics Inc. Company Name:
FLGT Stock Symbol:
NASDAQ Market:
Fulgent Genetics Inc. Website:
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its second quarter 2024 financial results be...
2024-07-01 14:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-21 15:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...